Global Generic Sterile Injectable Market, By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics), Therapeutic Application (Cancer, Diabetes, Cardiovascular Diseases, Central Nervous System, Infectious Disorders, Musculoskeletal), Distribution Channel (Hospitals, Drug Stores, Pharmacies, Online Pharmacies), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

  • Published On : Jun 2017 |
  • Pages : 270 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Generic Sterile Injectable Market – Paving the Way for Cost-effective Medication

The generic sterile injectable refers to biologics that are used for the treatment of various drugs and has same active ingredients to that of the branded versions of it, however the inactive contents of the drugs can be varied. The process of manufacturing generic sterile injectable is equivalent in the terms of the FDA regulations to that of the branded counterparts. A disease is characterized as chronic if it lasts for over three months within the patient according to the U.S. National Center for Health Statistics. The chronic diseases are one of the major causes of mortality as these diseases cannot easily be cured by vaccines and healthcare medication. According to the World Health Organization (WHO) in 2015, the non- communicable chronic diseases attributed to over 38 million death per year. These diseases include arthritis, diabetes, asthma, cardiovascular diseases, cancer, and also the viral diseases such as hepatitis C and HIV/AIDS. According to the 2013 fact sheet of Centers of Disease Control and Prevention (CDC), arthritis is suggested to be the most common cause of disability due to which 22 million doctor diagnosed patients have obstructed physical activity due to arthritis. According to the same report, around half of the U.S. population, i.e. 47% people have at least one major risk factor for cardiovascular disease, which mainly includes uncontrolled LDL cholesterol, high blood pressure, and smoking habits. The high prevalence rates of these diseases will inadvertently drive growth of the global generic sterile injectable market.

The global generic sterile injectable market was valued at US$ 42,900 million in 2015 and is expected to witness a CAGR of 10.2% during the forecast period (2017–2025).

Figure 1. Global Generic Sterile Injectable Market Share, By Drug Type (%)

generic sterile injectable market

Source: Coherent Market Insights Analysis (2017)

Rapid increase in the prevalence of chronic diseases globally drives the global generic sterile injectable market

Growing prevalence of chronic diseases and rapidly increasing ageing population that are highly susceptible to chronic diseases are major factors impacting growth of generic sterile injectable market in North America. Increasing number of chronic disorders such as cancer and diabetes as well as the consequent rise in demand for newer generic injectable across various countries in Europe would further fuel growth of the market in the region. However, stringent regulations by U.S. FDA such as, monitoring of the flexible intravenous (IV) solution bags from exposure to rough surfaces during labelling and packaging for any microscopic punctures or holes on the surface of the bag in order to avoid the microscopic defects that may lead to microbial contamination. However, the branded counterpart of the generic sterile injectable is more expensive and thus, cannot be afforded by a common population. Difficulties faced by manufacturing companies, in order to meet rising demands for these injectable in the hospitals, pharmacies, and drugs stores is one of the major concerns that may result in hampering the growth of the market. However, various dominant key holders are involved in acquiring small pharmaceutical companies to build a robust product portfolio of generic sterile injectable to fulfill the demand of these medications.

Key players indulged in strategic implementation of various policies for the product portfolio expansion of the generic sterile injectable

  • In 2016, Baxter acquired Claris’ Injectables, a 15 years old global generic injectable pharmaceutical company for the production of injectable medicines such as anesthesia and analgesics, anti-infective, renal, and critical care medications
  • Baxter in 2017, has also signed an agreement with Dorizoe, an India based life sciences company manufacturing generic sterile injectable. The duo is expected to develop more than 20 generic injectable products including oncolytic and cardiovascular medicines.
  • Fresenius Kabi, in 2016, announced a major investment of US$ 250 million to its U.S.-based manufacturing site over a period of 10 years, for expanding its capabilities of production of generic injectable and sterile injectable.
  • Other landmark acquisitions to boost the global generic sterile injectable market consists Hikma acquiring the assets of the Bedford Laboratories and Sun Pharma’s acquisition of Pharmalucence in 2014 that resulted in benchmarking sales of generic sterile injectable.

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.

Market Dynamics

The growing incidence and prevalence of chronic as well as infectious diseases and musculoskeletal disorders is a key factor fueling growth of the global generic sterile injectable market. About 53% of the disease burden is contributed by non- communicable diseases in India according to the National Health System Resource Centre (NHSRC) in 2016, which accounts up to 37 million deaths in India annually. As per the Chronic Disease Prevention and Health Promotion by the Centers for Disease Control and prevention (CDC), 117 million people in the U.S., suffered from one or more chronic diseases and two of these chronic diseases, heart diseases and cancer jointly accounted nearly 48% of all the deaths. Apart from prevalence of chronic diseases, several other factors that are responsible to fuel the growth of generic sterile injectable market includes rise in prevalence of infectious diseases such as malaria and tuberculosis and its cost effective treatments in emerging economies as well as the musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis and osteoporosis are also responsible for accelerating demand for generic sterile injectable. Product portfolio expansion and development of new products that can be used in the treatment of these diseases, are some of the other factors augmenting growth of the global generic sterile injectable market. However, the complex regulatory guidelines by FDA for production procedures and stringent regulations for ANDA filings are impeding growth of the global generic sterile injectable market.

Market Taxonomy

This report segments the global generic sterile injectable market on the basis of drug type, therapeutic application, distribution channel, and geography. On the basis of drug type, the generic sterile injectable market is segmented into Monoclonal antibodies, cytokines, insulin, peptide hormones, vaccines, immunoglobulins, blood factors, peptide antibiotics and others. On the basis of therapeutic application, the generic sterile injectable market is segmented into cancer, diabetes, cardiovascular diseases, central nervous system, infectious disorders, musculoskeletal and others. On the basis of end-user, the generic sterile injectable market is segmented into hospital, drug stores, pharmacies and online pharmacies. For comprehensive understanding of market dynamics, the global generic sterile injectable market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

  • This report provides in-depth analysis of the global generic sterile injectable and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for the generic sterile injectable market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global generic sterile injectable market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Baxter Inc., Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma, Dr. Reddy’s, Mylan, AstraZeneca Plc and Merck & Co. Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics
  • The global generic sterile injectable market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers for generic sterile injectable market, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the generic sterile injectable market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Generic Sterile Injectable Market, By Drug Type:
    • Monoclonal Antibodies
    • Cytokines
    • Insulin
    • Peptide Hormones
    • Vaccines
    • Immunoglobulins
    • Blood Factors
    • Peptide Antibiotics
    • Others
  • Global Generic Sterile Injectable Market, By Therapeutic Application:
    • Cancer
    • Diabetes
    • Cardiovascular Diseases
    • Central Nervous System
    • Infectious Disorders
    • Musculoskeletal
    • Others
  • Global Generic Sterile Injectable Market, By Distribution Channel:
    • Hospitals
    • Drug Stores
    • Pharmacies
    • Online Pharmacies
  • Global Generic Sterile Injectable Market, By Geography:
    • North America
      • U.S.
        • U.S. Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • U.S. Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • U.S. Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Canada
        • Canada Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Canada Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Canada Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
    • Europe
      • U.K.
        • U.K. Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • U.K. Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • U.K. Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Germany
        • Germany Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Germany Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Germany Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Italy
        • Italy Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Italy Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Italy Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • France
        • France Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • France Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • France Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Spain
        • Spain Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Spain Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Spain Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Russia
        • Russia Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Russia Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Russia Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Rest of Europe
        • Rest of Europe Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Rest of Europe Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Rest of Europe Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
    • Asia-Pacific
      • China
        • China Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • China Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • China Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • India
        • India Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • India Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • India Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Japan
        • Japan Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Japan Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Japan Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • ASEAN
        • ASEAN Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • ASEAN Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • ASEAN Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Australia
        • Australia Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Australia Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Australia Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • South Korea
        • South Korea Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • South Korea Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • South Korea Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Rest of Asia Pacific
        • Rest of Asia Pacific Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Rest of Asia Pacific Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Rest of Asia Pacific Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
    • Latin America
      • Brazil
        • Brazil Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Brazil Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Brazil Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Mexico
        • Mexico Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Mexico Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Mexico Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Rest of Latin America
        • Rest of Latin America Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Rest of Latin America Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Rest of Latin America Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
    • Middle East
      • GCC
        • GCC Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • GCC Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • GCC Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Israel
        • Israel Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Israel Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Israel Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Rest of Middle East
        • Rest of Middle East Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Rest of Middle East Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Rest of Middle East Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
    • Africa
      • North Africa
        • North Africa Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • North Africa Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • North Africa Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • Central Africa
        • Central Africa Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • Central Africa Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • Central Africa Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
      • South Africa
        • South Africa Generic Sterile Injectable Market, By Drug Type:
          • Monoclonal Antibodies
          • Cytokines
          • Insulin
          • Peptide Hormones
          • Vaccines
          • Immunoglobulins
          • Blood Factors
          • Peptide Antibiotics
          • Others
        • South Africa Generic Sterile Injectable Market, By Therapeutic Application:
          • Cancer
          • Diabetes
          • Cardiovascular Diseases
          • Central Nervous System
          • Infectious Disorders
          • Musculoskeletal
          • Others
        • South Africa Generic Sterile Injectable Market, By Distribution Channel:
          • Hospitals
          • Drug Stores
          • Pharmacies
          • Online Pharmacies
  • Company Profiles
    • 3M *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Baxter Inc.
    • Fresenius Kabi
    • Pfizer/Hospira
    • Novartis/Sandoz
    • Teva
    • Hikma
    • Sun Pharma
    • Dr. Reddy’s
    • Mylan
    • AstraZeneca Plc
    • Merck & Co., Inc.
    • Hellberg Safety Ab

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Drug Type
      • Market Snippet By Therapeutic Application
      • Market Snippet By Distribution Channel
      • Market Snippet By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
    • Industry Trend
    • Mergers and Acquisitions
    • Patents and Exclusivity
    • Key Development
  4. Global Generic Sterile Injectables Market, By Drug Type, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Monoclonal Antibodies
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Cytokines
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Insulin
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Peptide Hormones
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Immunoglobulins
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Blood Factors
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Peptide Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
  5. Global Generic Sterile Injectables Market, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Central Nervous Systems
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Infectious Disorders
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Musculoskeleton
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
  6. Global Generic Sterile Injectables Market, By Distribution Channel, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Drug Stores
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
  7. Global Generic Sterile Injectables Market, By Geography, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, For Regions, 2017 - 2025
    • North America
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2017 - 2025
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
    • Europe
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2017 - 2025
        • Germany
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Spain
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2017 - 2025
        • China
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
    • Latin America
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2017 - 2025
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Argentina
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
    • Middle East
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2017 - 2025
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
    • Africa
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, By Country, 2017 - 2025
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Million)
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Baxter Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Fresenius Kabi
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Pfizer/ Hospira
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Novartis/ Sandoz
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Teva
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Hikma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sun Pharma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Dr. Reddy’s
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Mylan
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • AstraZeneca Plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 45 figures on "Global Generic Sterile Injectable Market - Global forecast to 2025”.  

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.